Back
Norfolk Southern 10K Form
Buy
57
NSC
Norfolk Southern
Last Price:
255.00
Seasonality Move:
2.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-02-05 | 10K | NSC/Norfolk Southern Annual |
2023-10-25 | 10Q | NSC/Norfolk Southern Quarterly |
2023-07-27 | 10Q | NSC/Norfolk Southern Quarterly |
2023-04-26 | 10Q | NSC/Norfolk Southern Quarterly |
2023-02-03 | 10K | NSC/Norfolk Southern Annual |
2022-10-26 | 10Q | NSC/Norfolk Southern Quarterly |
Receive NSC News And Ratings
See the #1 stock for the next 7 days that we like better than NSC
NSC Financial Statistics
Sales & Book Value
Annual Sales: | $12.16B |
---|---|
Cash Flow: | $-180M |
Price / Cash Flow: | 68.96 |
Annual Sales: | $56.63 |
Price / Book: | 4.45 |
Profitability
EPS (TTM): | 8.02000 |
---|---|
Net Income (TTM): | $1.83B |
Gross Margin: | $4.44B |
Return on Equity: | 14.39% |
Return on Assets: | 4.57% |
Norfolk Southern Earnings Forecast
Key Norfolk Southern Financial Ratios
- The Gross Profit Margin over the past 40 years for NSC is 36.48%.
- The Selling, General & Administrative Expenses for NSC have been equal to -0.53% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 39.52% of Operating Income.
- The Net Earning history of NSC is 15.03% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 25 years.
Norfolk Southern Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Railroads |
Sector: | Industrials |
Current Symbol: | NSC |
CUSIP: | 655844 |
Website: | norfolksouthern.com |
Debt
Debt-to-Equity Ratio: | 1.34 |
---|---|
Current Ratio: | 1.24 |
Quick Ratio: | 1.03 |
Price-to-Earnings
Trailing P/E Ratio: | 31.39 |
---|---|
Forward P/E Ratio: | 18.3 |
NSC Technical Analysis vs Fundamental Analysis
Buy
57
Norfolk Southern (NSC)
is a Buy
Is Norfolk Southern a Buy or a Sell?
-
Norfolk Southern stock is rated a Buy
The current Norfolk Southern [NSC] share price is $251.72. The Score for NSC is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.